In its annual report outlined the progress in the work of the International Accounting Standards Board and the International Sustainability Standards Board in 2025.
Efforts to take advantage of the dramatic expansion of the Low-Income Housing Tax Credit have bumped up against some unintended consequences, say investors and developers.
In addition to delivering two approved medicines to Biogen’s portfolio, the acquisition of Apellis Pharmaceuticals will support the future launch of the pharma’s own kidney disease asset, currently in multiple Phase 3 trials.
The Internal Revenue Service canceled contracts as part of the federal effort to reduce overall spending — but the effect it will have on taxpayer services is yet to be seen.